Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
28,439,871
-
Share change
-
+1,244,367
-
Total reported value
-
$216,166,640
-
Price per share
-
$7.60
-
Number of holders
-
37
-
Value change
-
+$10,002,907
-
Number of buys
-
17
-
Number of sells
-
15
Institutional Holders of BELLUS HEALTH INC NEW - COM NEW (BLU) as of Q4 2019
As of 31 Dec 2019,
BELLUS HEALTH INC NEW - COM NEW (BLU) was held by
37 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
28,439,871 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, RTW INVESTMENTS, LP, FMR LLC, Polar Capital LLP, FIRST MANHATTAN CO, BOXER CAPITAL, LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., ACUTA CAPITAL PARTNERS, LLC, CITADEL ADVISORS LLC, and Samsara BioCapital, LLC.
This page lists
37
institutional shareholders reporting positions in this security
for the Q4 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.